Cell Biochemistry and Biophysics

, Volume 72, Issue 2, pp 453–459 | Cite as

Sorcin Enhances Metastasis and Promotes Epithelial-to-Mesenchymal Transition of Colorectal Cancer

  • Weihua Tong
  • Donghui Sun
  • Quan Wang
  • Jian SuoEmail author
Original Paper


Sorcin, a soluble resistance-related calcium-binding protein, belongs to the small penta-EF-hand family. Recent study reported that upregulation of sorcin correlated with metastasis and poor prognosis of colorectal cancer (CRC). In the present study, we explored the regulatory role of sorcin in CRC metastasis. To investigate the role of sorcin in CRC metastasis, sorcin overexpressed with empty vector as control in CRC cell line (HCT116). The effect of sorcin overexpression on cell migration and invasion was evaluated via wound healing and transwell assay, respectively. Sorcin-induced changes in EMT process were evaluated by estern blot. Furthermore, the role of PI3K/Akt in the regulatory effect of sorcin on cell migration and invasion, and EMT process was explored by suppressing Akt activity in sorcin-overexpressed HCT116 cells. Sorcin overexpression in HCT116 cells resulted in a significant increase in cell migration and invasion. Sorcin overexpression also markedly promoted the EMT process. More importantly, our results revealed that sorcin stimulated EMT process through activating PI3K/Akt signaling. In summary, this study indicated that the promoting effect of sorcin on CRC metastasis was, at least in part, through PI3K/Akt signaling. The findings in this study highlight the effectiveness and therapeutic potential to utilize sorcin-targeted strategies in the treatment of CRC.


Sorcin Metastasis Cell migration Invasion EMT Akt 


  1. 1.
    Byeon, J. S., et al. (2007). Colorectal neoplasm in asymptomatic Asians: A prospective multinational multicenter colonoscopy survey. Gastrointestinal Endoscopy, 65(7), 1015–1022.PubMedCrossRefGoogle Scholar
  2. 2.
    Chaffer, C. L., & Weinberg, R. A. (2011). A perspective on cancer cell metastasis. Science, 331(6024), 1559–1564.PubMedCrossRefGoogle Scholar
  3. 3.
    Colotti, G., et al. (2014). Sorcin, a calcium binding protein involved in the multidrug resistance mechanisms in cancer cells. Molecules, 19(9), 13976–13989.PubMedCrossRefGoogle Scholar
  4. 4.
    Cunningham, D., et al. (2010). Colorectal cancer. Lancet, 375(9719), 1030–1047.PubMedCrossRefGoogle Scholar
  5. 5.
    Farrell, E. F., et al. (2003). Sorcin inhibits calcium release and modulates excitation-contraction coupling in the heart. Journal of Biological Chemistry, 278(36), 34660–34666.PubMedCrossRefGoogle Scholar
  6. 6.
    Ferlay, J., et al. (2010). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. International Journal of Cancer, 127(12), 2893–2917.CrossRefGoogle Scholar
  7. 7.
    Gao, Y., et al. (2015). Reversing effect and mechanism of soluble resistance-related calcium-binding protein on multidrug resistance in human lung cancer A549/DDP cells. Molecular Medicine Reports, 11(3), 2118–2124.Google Scholar
  8. 8.
    Gupta, G. P., & Massague, J. (2006). Cancer metastasis: Building a framework. Cell, 127(4), 679–695.PubMedCrossRefGoogle Scholar
  9. 9.
    He, Q., et al. (2011). Overexpression of sorcin results in multidrug resistance in gastric cancer cells with up-regulation of P-gp. Oncology Reports, 25(1), 237–243.PubMedGoogle Scholar
  10. 10.
    Hu, Y., et al. (2013). Inhibition of sorcin reverses multidrug resistance of K562/A02 cells and MCF-7/A02 cells via regulating apoptosis-related proteins. Cancer Chemotherapy and Pharmacology, 72(4), 789–798.PubMedCrossRefGoogle Scholar
  11. 11.
    Hu, Y., et al. (2014). Sorcin silencing inhibits epithelial-to-mesenchymal transition and suppresses breast cancer metastasis in vivo. Breast Cancer Research and Treatment, 143(2), 287–299.PubMedCrossRefGoogle Scholar
  12. 12.
    Jemal, A., et al. (2009). Cancer statistics, 2009. CA: A Cancer Journal for Clinicians, 59(4), 225–249.Google Scholar
  13. 13.
    Jemal, A., et al. (2011). Global cancer statistics. CA: A Cancer Journal for Clinicians, 61(2), 69–90.Google Scholar
  14. 14.
    Kawakami, M., et al. (2007). Knock-down of sorcin induces up-regulation of MDR1 in HeLa cells. Biological and Pharmaceutical Bulletin, 30(6), 1065–1073.PubMedCrossRefGoogle Scholar
  15. 15.
    Lalioti, V. S., et al. (2014). Sorcin links calcium signaling to vesicle trafficking, regulates polo-like kinase 1 and is necessary for mitosis. PLoS One, 9(1), e85438.PubMedCentralPubMedCrossRefGoogle Scholar
  16. 16.
    Li, X., et al. (2013). SOX2 promotes tumor metastasis by stimulating epithelial-to-mesenchymal transition via regulation of WNT/beta-catenin signal network. Cancer Letters, 336(2), 379–389.PubMedCrossRefGoogle Scholar
  17. 17.
    Liao, W., et al. (2013). Silencing of DLGAP5 by siRNA significantly inhibits the proliferation and invasion of hepatocellular carcinoma cells. PLoS One, 8(12), e80789.PubMedCentralPubMedCrossRefGoogle Scholar
  18. 18.
    Liu, X., et al. (2014). Reversing effect of sorcin in the drug resistance of human nasopharyngeal carcinoma. The Anatomical Record (Hoboken), 297(2), 215–221.CrossRefGoogle Scholar
  19. 19.
    Maddalena, F., et al. (2011). Sorcin induces a drug-resistant phenotype in human colorectal cancer by modulating Ca(2+) homeostasis. Cancer Research, 71(24), 7659–7669.PubMedCrossRefGoogle Scholar
  20. 20.
    Meyers, M. B., et al. (1995). Association of sorcin with the cardiac ryanodine receptor. Journal of Biological Chemistry, 270(44), 26411–26418.PubMedCrossRefGoogle Scholar
  21. 21.
    Meyers, M. B., et al. (1998). Sorcin associates with the pore-forming subunit of voltage-dependent L-type Ca2+ channels. Journal of Biological Chemistry, 273(30), 18930–18935.PubMedCrossRefGoogle Scholar
  22. 22.
    Meyers, M. B., et al. (2003). Sorcin regulates excitation-contraction coupling in the heart. Journal of Biological Chemistry, 278(31), 28865–28871.PubMedCrossRefGoogle Scholar
  23. 23.
    Parekh, H. K., et al. (2002). Overexpression of sorcin, a calcium-binding protein, induces a low level of paclitaxel resistance in human ovarian and breast cancer cells. Biochemical Pharmacology, 63(6), 1149–1158.PubMedCrossRefGoogle Scholar
  24. 24.
    Qi, J., et al. (2006). Overexpression of sorcin in multidrug resistant human leukemia cells and its role in regulating cell apoptosis. Biochemical and Biophysical Research Communications, 349(1), 303–309.PubMedCrossRefGoogle Scholar
  25. 25.
    Qu, Y., et al. (2010). Comparative proteomic profiling identified sorcin being associated with gemcitabine resistance in non-small cell lung cancer. Medical Oncology, 27(4), 1303–1308.PubMedCrossRefGoogle Scholar
  26. 26.
    Spano, D., et al. (2012). Molecular networks that regulate cancer metastasis. Seminars in Cancer Biology, 22(3), 234–249.PubMedCrossRefGoogle Scholar
  27. 27.
    Steeg, P. S. (2006). Tumor metastasis: mechanistic insights and clinical challenges. Nature Medicine, 12(8), 895–904.PubMedCrossRefGoogle Scholar
  28. 28.
    Tan, Y., et al. (2003). Expression of sorcin predicts poor outcome in acute myeloid leukemia. Leukemia Research, 27(2), 125–131.PubMedCrossRefGoogle Scholar
  29. 29.
    Thiery, J. P., et al. (2009). Epithelial-mesenchymal transitions in development and disease. Cell, 139(5), 871–890.PubMedCrossRefGoogle Scholar
  30. 30.
    Yamagishi, N., et al. (2014). Increased expression of sorcin is associated with multidrug resistance in leukemia cells via up-regulation of MDR1 expression through cAMP response element-binding protein. Biochemical and Biophysical Research Communications, 448(4), 430–436.PubMedCrossRefGoogle Scholar
  31. 31.
    Zamparelli, C., et al. (2010). Activation of the cardiac Na(+)–Ca(2+) exchanger by sorcin via the interaction of the respective Ca(2+)-binding domains. Journal of Molecular and Cellular Cardiology, 49(1), 132–141.PubMedCentralPubMedCrossRefGoogle Scholar
  32. 32.
    Zhou, Y., et al. (2006). Sorcin, an important gene associated with multidrug-resistance in human leukemia cells. Leukemia Research, 30(4), 469–476.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2015

Authors and Affiliations

  1. 1.Department of Gastrointestinal-Colorectal SurgeryFirst Hospital of Jilin UniversityChangchunChina

Personalised recommendations